Aurora Cannabis (TSE:ACB) Trading 8.6% Higher

Shares of Aurora Cannabis Inc (TSE:ACB) traded up 8.6% on Thursday . The stock traded as high as C$2.99 and last traded at C$2.92, 3,099,094 shares traded hands during trading. A decline of 75% from the average session volume of 12,272,015 shares. The stock had previously closed at C$2.69.

Several research analysts have weighed in on the company. Cantor Fitzgerald upgraded Aurora Cannabis from a “neutral” rating to an “overweight” rating in a report on Friday, November 15th. Pi Financial dropped their price target on Aurora Cannabis from C$7.00 to C$6.00 and set a “buy” rating on the stock in a research note on Wednesday, November 20th. Laurentian set a C$4.75 price target on Aurora Cannabis and gave the company a “buy” rating in a research note on Tuesday, December 17th. AltaCorp Capital reissued a “sector perform” rating on shares of Aurora Cannabis in a research note on Wednesday, December 18th. Finally, Jefferies Financial Group downgraded Aurora Cannabis from a “buy” rating to a “hold” rating and dropped their price target for the company from C$7.00 to C$3.00 in a research note on Tuesday, December 24th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have assigned a buy rating to the company’s stock. Aurora Cannabis has a consensus rating of “Hold” and a consensus price target of C$8.59.

The company has a 50 day simple moving average of C$2.88 and a 200-day simple moving average of C$5.89. The stock has a market cap of $2.41 billion and a price-to-earnings ratio of -7.76. The company has a current ratio of 1.27, a quick ratio of 0.63 and a debt-to-equity ratio of 17.82.

Aurora Cannabis (TSE:ACB) last released its quarterly earnings results on Thursday, November 14th. The company reported C$0.01 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of C($0.04) by C$0.05. The firm had revenue of C$75.25 million during the quarter, compared to analyst estimates of C$95.87 million. Equities analysts forecast that Aurora Cannabis Inc will post -0.16 earnings per share for the current fiscal year.

About Aurora Cannabis (TSE:ACB)

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Further Reading: Balanced Fund

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.